319 related articles for article (PubMed ID: 7958856)
1. Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
Dynlacht BD; Flores O; Lees JA; Harlow E
Genes Dev; 1994 Aug; 8(15):1772-86. PubMed ID: 7958856
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
3. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
Woo MS; Sánchez I; Dynlacht BD
Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
[TBL] [Abstract][Full Text] [Related]
4. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
5. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
[TBL] [Abstract][Full Text] [Related]
6. p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression.
Zerfass-Thome K; Schulze A; Zwerschke W; Vogt B; Helin K; Bartek J; Henglein B; Jansen-Dürr P
Mol Cell Biol; 1997 Jan; 17(1):407-15. PubMed ID: 8972221
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
10. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
13. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
14. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
15. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
16. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees E; Faha B; Dulic V; Reed SI; Harlow E
Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
Zhang K; Kumar R
Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
[TBL] [Abstract][Full Text] [Related]
20. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
